+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sequencing Reagents Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012646
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sequencing Reagents Market is projected to reach USD 11.58 Billion in 2026. It is expected to continue growing at a CAGR of 18.12%, reaching USD 31.59 Billion by 2032.

Sequencing reagents are the recurring consumables that enable next-generation sequencing workflows, including library preparation enzymes, adapters, primers, buffers, cluster generation chemistry, flow cell reagents, and signal detection materials. Demand is structurally linked to rising sequencing volume in oncology, infectious disease surveillance, reproductive health, pharmacogenomics, agricultural genomics, and population-scale research.

Verified industry signals show sustained adoption: the National Human Genome Research Institute documents that genome sequencing costs have fallen from the multi-billion-dollar Human Genome Project era to below USD 1,000 for many whole-genome workflows, while high-throughput platforms continue to target lower per-genome reagent economics. This cost compression makes reagent performance, lot consistency, automation compatibility, and supply reliability central purchasing criteria for laboratories moving from discovery research to clinical-grade genomics.

Transformative Shifts in Sequencing Reagents

The sequencing reagents landscape is shifting from research-centric purchasing toward clinical, biopharma, and public-health applications that require validated chemistry and traceable quality systems. Short-read sequencing remains widely used for high-throughput applications, while long-read, single-cell, spatial, and methylation sequencing workflows are expanding reagent requirements for specialized enzymes, barcoding chemistry, and high-integrity sample preparation.

Three verified shifts are reshaping competition: regulated clinical testing is raising expectations for reproducibility; decentralized sequencing is increasing demand for simplified kits; and multiomics is pulling sequencing reagents into integrated DNA, RNA, epigenomic, proteogenomic, and spatial biology workflows. Suppliers that combine chemistry innovation with instrument-agnostic workflow support are better positioned as laboratories standardize scalable protocols and seek lower failure rates across complex sample types.

Cumulative Impact of AI on Sequencing Reagents

Artificial intelligence is compounding the value of sequencing reagents by improving base calling, run quality prediction, variant interpretation, error correction, contamination detection, and workflow optimization. AI-enabled analysis does not replace wet-lab chemistry; it increases the need for cleaner libraries, lower bias, improved read accuracy, and standardized reagent performance because computational models depend on high-quality input data.

In practice, AI is accelerating reagent development through enzyme engineering, primer design, adaptive sampling, anomaly detection, and digital quality control. Peer-reviewed tools such as DeepVariant have demonstrated that machine learning can improve variant calling accuracy, while nanopore and high-throughput sequencing workflows increasingly use algorithmic signal processing. The cumulative result is tighter integration between chemistry, instruments, software, and bioinformatics, making reagent consistency a foundational input for reliable AI-assisted genomics.

Regional Insights Across Major Markets

North America remains a leading sequencing reagents region because the United States and Canada combine academic genomics infrastructure, biopharma R&D, clinical laboratory networks, and federal research programs such as NIH-supported genomics initiatives. Europe benefits from coordinated health-data and genomics programs across the European Union, the United Kingdom, Germany, France, Italy, and Spain, with regulatory emphasis on quality, privacy, clinical evidence, and in vitro diagnostic compliance.

Asia-Pacific is expanding through national genome programs, cancer research, reproductive health testing, rare disease studies, agricultural genomics, and growing sequencing capacity in China, India, Japan, South Korea, Australia, and ASEAN economies. Latin America, led by Brazil and Mexico, is increasing adoption through infectious disease surveillance, academic genomics, oncology research, and food and agricultural applications. The Middle East is supported by GCC precision medicine investments and national health transformation programs, while Africa’s demand is tied to pathogen surveillance, population genomics, antimicrobial resistance monitoring, and capacity-building partnerships supported by public-health agencies and research networks.

Strategic Group Insights

G7 economies anchor substantial demand for high-quality sequencing reagents because they host advanced pharmaceutical research, reference laboratories, cancer centers, public-health sequencing programs, and academic genomics hubs. The European Union adds procurement scale, cross-border research coordination, and harmonized regulatory pathways, while NATO countries increasingly recognize genomic surveillance as part of biosecurity, biodefense readiness, and public-health preparedness.

BRICS markets are important adoption engines as China, India, Brazil, Russia, and South Africa expand local sequencing capacity, infectious disease monitoring, agricultural genomics, and more representative genomic databases. ASEAN countries are building regional momentum through pathogen monitoring, reproductive health, oncology research, and crop and aquaculture genomics. GCC countries are notable for population genomics and precision medicine investments, which favor clinically reliable reagents, automated workflows, accredited laboratory practices, and secure supply chains for long-term national programs.

Country-Level Sequencing Reagents Insights

The United States is the largest innovation and adoption hub, supported by NIH funding, FDA-regulated diagnostics, biopharma demand, public-health sequencing, and the All of Us Research Program’s one-million-participant goal. Canada contributes through national genomics networks and precision health initiatives, while Mexico and Brazil are scaling sequencing for public health, cancer research, inherited disease, agriculture, and pathogen surveillance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine strong clinical research with national genomics programs, oncology sequencing, rare disease initiatives, and molecular diagnostics adoption, while Russia maintains scientific capacity despite procurement and cross-border supply complexity. China continues to scale high-throughput sequencing across clinical research, reproductive health, oncology, and agriculture; India is broadening genomic medicine through initiatives such as GenomeIndia and expanding infectious disease and rare disease capabilities; Japan applies sequencing in cancer, rare disease, pharmacogenomics, and aging-related research; Australia supports national genomic medicine networks and public-health genomics; and South Korea advances clinical genomics, precision oncology, infectious disease monitoring, and technology-enabled hospital adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize reagent reliability, regulatory documentation, and workflow compatibility across short-read, long-read, targeted, whole-genome, RNA, methylation, and single-cell sequencing applications. Differentiation should focus on reduced input requirements, faster library preparation, lower duplication rates, improved GC coverage, contamination controls, automation-ready formats, and validated performance across formalin-fixed, low-biomass, and degraded samples.

Commercial teams should align product portfolios with clinical validation, biopharma outsourcing, public-health surveillance, agrigenomics, and population genomics demand. Supply-chain resilience is essential: dual sourcing of critical raw materials, regional inventory buffers, cold-chain discipline, and transparent quality metrics can reduce disruption risk. Partnerships with instrument providers, cloud bioinformatics platforms, accredited laboratories, and translational research networks can also increase workflow integration, customer retention, and confidence in reproducible sequencing outcomes.

Research Methodology

This executive summary is based on a structured review of verified public sources, regulatory information, peer-reviewed genomics literature, public institutional disclosures, and recognized authorities including NIH, NHGRI, FDA, OECD, WHO, national genome programs, and public-health agencies. Insights were triangulated across technology adoption, clinical use cases, regional policy, AI-enabled genomics, and supply-chain indicators.

The methodology emphasizes data-backed interpretation rather than unsupported market sizing, market share, or forecasting. Evidence was assessed for source credibility, recency, applicability to sequencing reagents, and consistency across independent references. Qualitative findings were organized by technology shift, AI impact, geography, strategic groups, and country-level demand drivers to support executive decision-making in sequencing consumables and genomics workflow strategy.

Conclusion

Sequencing reagents are becoming a strategic layer of the genomics value chain as sequencing moves deeper into clinical care, pharmaceutical research, public health, agriculture, and population-scale programs. Cost declines have broadened access, but customers increasingly evaluate suppliers on reproducibility, documentation, automation compatibility, sample-type flexibility, and end-to-end workflow performance.

The next phase of adoption will be shaped by AI-enabled analytics, multiomics integration, regional genomics investments, public-health surveillance, and stronger quality expectations. Organizations that deliver robust chemistry, secure supply, and clinically credible support will be best positioned to capture durable demand in the global sequencing reagents market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sequencing Reagents Market, by Product Type
7.1. Adapters And Tags
7.2. Buffers And Solutions
7.3. Labeling Reagents
7.4. Nucleotides
7.5. Polymerases And Enzymes
7.5.1. Dna Polymerases
7.5.2. Ligases
7.5.3. Reverse Transcriptases
8. Sequencing Reagents Market, by Technology
8.1. Next-Generation Sequencing
8.2. Sanger Sequencing
8.3. Third-Generation Sequencing
9. Sequencing Reagents Market, by Sample Type
9.1. DNA Samples
9.2. RNA Samples
9.3. Cell Free DNA
10. Sequencing Reagents Market, by Application
10.1. Metagenomics Sequencing
10.2. RNA Sequencing
10.3. Targeted Sequencing
10.4. Whole Genome Sequencing
11. Sequencing Reagents Market, by End User
11.1. Academic Research
11.2. Contract Research Organizations
11.3. Healthcare And Diagnostic Laboratories
11.4. Pharmaceutical And Biotechnology Companies
12. Asia-Pacific Sequencing Reagents Market
13. Europe Sequencing Reagents Market
14. North America Sequencing Reagents Market
15. Latin America Sequencing Reagents Market
16. Africa Sequencing Reagents Market
17. Middle East Sequencing Reagents Market
18. NATO Sequencing Reagents Market
19. G7 Sequencing Reagents Market
20. BRICS Sequencing Reagents Market
21. European Union Sequencing Reagents Market
22. ASEAN Sequencing Reagents Market
23. GCC Sequencing Reagents Market
24. China Sequencing Reagents Market
25. United States Sequencing Reagents Market
26. Japan Sequencing Reagents Market
27. India Sequencing Reagents Market
28. Germany Sequencing Reagents Market
29. United Kingdom Sequencing Reagents Market
30. Australia Sequencing Reagents Market
31. France Sequencing Reagents Market
32. South Korea Sequencing Reagents Market
33. Italy Sequencing Reagents Market
34. Canada Sequencing Reagents Market
35. Russia Sequencing Reagents Market
36. Brazil Sequencing Reagents Market
37. Mexico Sequencing Reagents Market
38. Spain Sequencing Reagents Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. 10x Genomics Inc
40.2. Agilent Technologies Inc
40.3. BGI Genomics Co Ltd
40.4. Bio-Rad Laboratories Inc
40.5. Danaher Corp
40.6. Element Biosciences Inc
40.7. Eurofins Scientific SE
40.8. Fulgent Genetics Inc
40.9. GenScript Biotech Corp
40.10. Illumina Inc
40.11. LGC Limited
40.12. MGI Tech Co Ltd
40.13. NeoGenomics Laboratories Inc
40.14. Novogene Co Ltd
40.15. Oxford Nanopore Technologies PLC
40.16. Pacific Biosciences of California Inc
40.17. Paragon Genomics Inc
40.18. Promega Corp
40.19. Psomagen Inc
40.20. QIAGEN NV
40.21. Revvity Inc
40.22. Singular Genomics Systems Inc
40.23. SOPHiA GENETICS SA
40.24. Takara Bio Inc
40.25. Thermo Fisher Scientific Inc
40.26. Twist Bioscience Corp
40.27. Ultima Genomics Inc
List of Figures
FIGURE 1. GLOBAL SEQUENCING REAGENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SEQUENCING REAGENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SEQUENCING REAGENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SEQUENCING REAGENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. JAPAN SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SPAIN SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SEQUENCING REAGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ADAPTERS AND TAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ADAPTERS AND TAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ADAPTERS AND TAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BUFFERS AND SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BUFFERS AND SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BUFFERS AND SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL LABELING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL LABELING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL LABELING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NUCLEOTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL POLYMERASES AND ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL POLYMERASES AND ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL POLYMERASES AND ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DNA POLYMERASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DNA POLYMERASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DNA POLYMERASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LIGASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL LIGASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL LIGASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL REVERSE TRANSCRIPTASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THIRD-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THIRD-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THIRD-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DNA SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DNA SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DNA SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RNA SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RNA SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RNA SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CELL FREE DNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CELL FREE DNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CELL FREE DNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL METAGENOMICS SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL METAGENOMICS SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL METAGENOMICS SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HEALTHCARE AND DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HEALTHCARE AND DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HEALTHCARE AND DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 89. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 91. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 110. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 112. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. NATO SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. NATO SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. NATO SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 124. NATO SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. NATO SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. NATO SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. NATO SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. G7 SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. G7 SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. G7 SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 131. G7 SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. G7 SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 133. G7 SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. G7 SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. BRICS SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. BRICS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. BRICS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 138. BRICS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. BRICS SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 140. BRICS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. BRICS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 152. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 154. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. GCC SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GCC SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. GCC SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 159. GCC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. GCC SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 161. GCC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. GCC SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. CHINA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. CHINA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. CHINA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 166. CHINA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. CHINA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. CHINA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. CHINA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. JAPAN SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 180. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 182. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. INDIA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. INDIA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. INDIA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 187. INDIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. INDIA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 189. INDIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. INDIA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. GERMANY SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 192. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 194. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 196. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 201. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 203. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 208. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 210. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. FRANCE SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 215. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 217. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 220. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 222. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 224. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ITALY SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. ITALY SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. ITALY SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 229. ITALY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. ITALY SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 231. ITALY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. ITALY SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. CANADA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. CANADA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. CANADA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 236. CANADA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. CANADA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 238. CANADA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. CANADA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. RUSSIA SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 243. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 245. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. BRAZIL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 250. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 252. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. MEXICO SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 255. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 257. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 259. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. SPAIN SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2032 (USD MILLION)
TABLE 264. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 266. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Sequencing Reagents market report include:
  • 10x Genomics Inc
  • Agilent Technologies Inc
  • BGI Genomics Co Ltd
  • Bio-Rad Laboratories Inc
  • Danaher Corp
  • Element Biosciences Inc
  • Eurofins Scientific SE
  • Fulgent Genetics Inc
  • GenScript Biotech Corp
  • Illumina Inc
  • LGC Limited
  • MGI Tech Co Ltd
  • NeoGenomics Laboratories Inc
  • Novogene Co Ltd
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc
  • Paragon Genomics Inc
  • Promega Corp
  • Psomagen Inc
  • QIAGEN NV
  • Revvity Inc
  • Singular Genomics Systems Inc
  • SOPHiA GENETICS SA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp
  • Ultima Genomics Inc

Table Information